Your browser doesn't support javascript.
loading
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121).
Schoeberl, Birgit; Kudla, Art; Masson, Kristina; Kalra, Ashish; Curley, Michael; Finn, Gregory; Pace, Emily; Harms, Brian; Kim, Jaeyeon; Kearns, Jeff; Fulgham, Aaron; Burenkova, Olga; Grantcharova, Viara; Yarar, Defne; Paragas, Violette; Fitzgerald, Jonathan; Wainszelbaum, Marisa; West, Kip; Mathews, Sara; Nering, Rachel; Adiwijaya, Bambang; Garcia, Gabriela; Kubasek, Bill; Moyo, Victor; Czibere, Akos; Nielsen, Ulrik B; MacBeath, Gavin.
Afiliação
  • Schoeberl B; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Kudla A; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Masson K; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Kalra A; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Curley M; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Finn G; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Pace E; Celgene, San Francisco, CA, USA.
  • Harms B; PatientsLikeMe, Cambridge, MA, USA.
  • Kim J; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Kearns J; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Fulgham A; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Burenkova O; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Grantcharova V; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Yarar D; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Paragas V; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Fitzgerald J; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Wainszelbaum M; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • West K; Synlogic, Cambridge, MA, USA.
  • Mathews S; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Nering R; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Adiwijaya B; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Garcia G; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Kubasek B; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Moyo V; L.E.A.F. Pharmaceuticals, Radnor, PA, USA.
  • Czibere A; Merrimack Pharmaceuticals, Cambridge, MA, USA.
  • Nielsen UB; Torque, Cambridge, MA, USA.
  • MacBeath G; Merrimack Pharmaceuticals, Cambridge, MA, USA.
NPJ Syst Biol Appl ; 3: 16034, 2017.
Article em En | MEDLINE | ID: mdl-28725482
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: NPJ Syst Biol Appl Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: NPJ Syst Biol Appl Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos